Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Frontotemporal dementia.

H J Rosen1, J Lengenfelder, B Miller

  • 1Department of Neurology, University of California San Francisco, San Francisco, California 94143-1207

Neurologic Clinics
|November 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are amyotrophic lateral sclerosis patients cognitively normal?

Neurology·2003
Same author

Radiation hybrid map, physical map, and low-pass genomic sequence of the canine prcd region on CFA9 and comparative mapping with the syntenic region on human chromosome 17.

Genomics·2003
Same author

Hypothalamic control of gonadotropin secretion.

Progress in brain research·2003
Same author

The behavioral spectrum of tic disorders: a community-based study.

Neurology·2002
Same author

Early retinal damage in experimental diabetes: electroretinographical and morphological observations.

Experimental eye research·2002
Same author

Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.

Neurology·2002

Frontotemporal dementia (FTD) is a distinct neurodegenerative condition. Understanding its specific genetic and biochemical underpinnings is key to developing targeted treatments for FTD.

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Frontotemporal dementia (FTD) is a neurodegenerative disorder.
  • It presents distinct clinical and pathological features compared to Alzheimer's disease.
  • FTD's presentation varies based on the affected brain regions, leading to diverse symptoms like aphasia or behavioral changes.

Purpose of the Study:

  • To differentiate Frontotemporal dementia (FTD) from other causes of cognitive decline.
  • To highlight the relationship between the anatomic focus of degeneration and clinical presentation in FTD.
  • To emphasize the potential for targeted treatments through advancing FTD genetics and biochemistry.

Main Methods:

  • Clinical differentiation from other neurodegenerative diseases.

Related Experiment Videos

  • Correlation of anatomic degeneration patterns with specific clinical symptoms.
  • Review of current knowledge on FTD genetics and biochemistry.

    • Main Results:

    • FTD can be distinguished from Alzheimer's disease and other cognitive disorders.
    • The location of neurodegeneration in FTD dictates whether symptoms manifest as aphasia or behavioral changes.
    • Current research is expanding the understanding of FTD's genetic and biochemical basis.

    Conclusions:

    • FTD is a unique neurodegenerative disease with specific diagnostic criteria.
    • Understanding the neuroanatomical basis of FTD is crucial for diagnosis and management.
    • Further research into the genetics and biochemistry of FTD holds promise for future therapeutic interventions.